# Citations for Research Query

**Query:** # Mechanistic Hypothesis Search

You are evaluating a specific disease mechanism hypothesis for the Disorder
Mechanisms Knowledge Base. This is not a general disease overview. Use the
hypothesis YAML below as the seed claim, then search for evidence that supports,
refutes, qualifies, or competes with this hypothesis.

## Target Disease
- **Disease Name:** Pial Basement Membrane and Radial-Glial Endfoot Failure Module
- **Category:** Module

## Target Hypothesis
- **Hypothesis ID:** pial_boundary_overmigration_model
- **Hypothesis Label:** Pial Boundary-Failure Overmigration Model
- **Status in KB:** CANONICAL

## Seed Hypothesis YAML

```yaml
hypothesis_group_id: pial_boundary_overmigration_model
hypothesis_label: Pial Boundary-Failure Overmigration Model
status: CANONICAL
description: Pathogenic disruption of the pial ECM interface, especially through alpha-dystroglycan O-mannosylation
  or GPR56-COL3A1 signaling, weakens basement membrane integrity and radial-glial basal endfoot anchoring.
  The causal readout is not primarily slow or failed neuronal locomotion; it is loss of the cortical pial
  boundary that allows overmigration and ectopic extracortical/cobblestone-like tissue.
evidence:
- reference: PMID:18509043
  supports: SUPPORT
  evidence_source: MODEL_ORGANISM
  snippet: There are four crucial events in the development of cobblestone cortex, namely defective pial
    basement membrane (BM), abnormal anchorage of radial glial endfeet, mislocalized Cajal-Retzius cells,
    and neuronal overmigration.
  explanation: 'Defines the pial-boundary skeleton used by this module: basement membrane defect, radial-glial
    endfoot anchoring failure, Cajal-Retzius mislocalization, and overmigration.'
- reference: PMID:21768377
  supports: SUPPORT
  evidence_source: MODEL_ORGANISM
  snippet: Further studies demonstrated that Col3a1 null mutant mice exhibit overmigration of neurons
    beyond the pial basement membrane and a cobblestone-like cortical malformation similar to the phenotype
    seen in Gpr56 null mutant mice.
  explanation: Shows that loss of the GPR56 ligand COL3A1 produces the same pial-boundary overmigration
    phenotype as Gpr56 loss.
```

## Research Objective

Build a focused hypothesis-search report that answers:

1. What is the strongest direct evidence for this hypothesis?
2. What evidence argues against it, fails to reproduce it, or limits its scope?
3. Which claims are established, emerging, speculative, or contradicted?
4. Which patient subtypes, stages, tissues, cell types, molecular pathways, or
   biomarkers does the hypothesis best explain?
5. Which alternative or competing mechanistic hypotheses explain the same disease
   features better or more parsimoniously?
6. What are the explicit knowledge gaps: missing causal steps, unconfirmed edges,
   contradictory evidence, unknown source-to-target links, or source/data absences?
7. What experiments, cohorts, assays, datasets, or trials would most directly
   distinguish this hypothesis from alternatives?

Use primary literature whenever possible. Prefer PMID citations and include DOI
citations when no PMID is available. Treat reviews as orientation unless they
contain directly relevant synthesized evidence that should be clearly labeled as
review-level support.

## Required Output

### Executive Judgment

Give a concise verdict on the hypothesis as of the current literature:
supported, partially supported, unresolved, weakly supported, or refuted. Explain
the reasoning and the most important caveats.

### Evidence Matrix

Create a table with one row per important evidence item:

- Citation (PMID preferred)
- Evidence type (human clinical, model organism, in vitro, computational, review)
- Supports / refutes / qualifies / competing
- Mechanistic claim tested
- Key finding
- Disease subtype or context
- Confidence and limitations

### Mechanistic Causal Chain

Describe the causal chain implied by the hypothesis from upstream trigger to
clinical manifestation. Identify where the literature is strong, where the links
are inferred, and where there are missing causal steps.

### Knowledge Gaps

Identify explicit known unknowns surfaced by the search. Treat absence of
evidence as a curation-relevant finding only when the search actually checked for
it. Include:

- Unknown or weakly supported causal steps in the hypothesis
- Unconfirmed causal graph edges that need direct perturbation or longitudinal
  evidence
- Conflicting evidence, failed replications, or incompatible subtype-specific
  findings
- Unknown mechanism of action for relevant treatments, biomarkers, or
  interventions tied to this hypothesis
- Source-level or dataset-level absences, such as no relevant GenCC, ClinGen,
  trial, omics, or cohort evidence found as of the search date

For each gap, state the scope, why it matters, what was checked, and what
evidence or experiment would resolve it.

### Alternative Models

List competing or complementary hypotheses. For each, explain whether it is an
alternative to the seed hypothesis, a downstream consequence, an upstream cause,
or a parallel mechanism.

### Discriminating Tests

Recommend concrete studies or assays that would most efficiently test this
hypothesis against alternatives. Include patient stratification, biomarkers,
sample type, model system, perturbation, and expected result where applicable.

### Curation Leads

Provide candidate updates for the KB, but label these as leads requiring curator
verification. Include:

- candidate evidence references and exact abstract snippets to verify
- candidate pathophysiology nodes or edges
- candidate ontology terms for cell types and biological processes
- candidate subtype restrictions or status changes
- candidate `knowledge_gaps` or discussion prompts for unresolved causal claims,
  conflicting evidence, or explicit source/data absences

If the provider supports artifacts, produce artifact-friendly outputs such as an
evidence matrix, mechanistic diagram, knowledge-gap table, or comparison table.
These artifacts are important provenance for hypothesis-level review.

**Provider:** falcon
**Generated:** 2026-06-09T22:38:43.848978

1. nickolls2018therolesof pages 8-9
2. wong2023anadhesionsignaling pages 22-25
3. wong2023anadhesionsignaling pages 15-18
4. wong2023anadhesionsignaling pages 25-28
5. nickolls2018therolesof pages 15-15
6. amin2020theextracellularmatrix pages 10-10
7. wong2023anadhesionsignaling pages 18-22
8. carrier2025themicrotubulebindingprotein pages 13-16
9. carrier2025themicrotubulebindingprotein pages 1-4
10. ferent2020extracellularcontrolof pages 19-20
11. carrier2025themicrotubulebindingprotein pages 7-10
12. nickolls2018therolesof pages 5-6
13. wong2023anadhesionsignaling pages 46-51
14. wong2023anadhesionsignaling pages 51-55
15. https://doi.org/10.1101/2022.08.02.502565
16. https://doi.org/10.1007/s00018-024-05416-8
17. https://doi.org/10.1242/dmm.035931
18. https://doi.org/10.1101/2025.04.06.647459
19. https://doi.org/10.3389/fcell.2020.604448
20. https://doi.org/10.3389/fcell.2020.578341
21. https://doi.org/10.3390/cells10010003
22. https://doi.org/10.1101/2022.08.02.502565,
23. https://doi.org/10.1101/2025.04.06.647459,
24. https://doi.org/10.1242/dmm.035931,
25. https://doi.org/10.3389/fcell.2020.578341,
26. https://doi.org/10.3390/cells10010003,
27. https://doi.org/10.3389/fcell.2020.604448,
